Profund Advisors’s Merit Medical Systems MMSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $218K | Buy |
+3,150
| New | +$208K | 0.01% | 1027 |
|
|
2026
Q1 | – | Sell |
-4,342
| Closed | -$383K | – | 1223 |
|
|
2025
Q4 | $383K | Buy |
4,342
+1,586
| +58% | +$135K | 0.01% | 708 |
|
|
2025
Q3 | $229K | Sell |
2,756
-176
| -6% | -$15.3K | 0.01% | 896 |
|
|
2025
Q2 | $274K | Buy |
2,932
+211
| +8% | +$20K | 0.01% | 737 |
|
|
2025
Q1 | $288K | Sell |
2,721
-338
| -11% | -$34.9K | 0.01% | 709 |
|
|
2024
Q4 | $296K | Buy |
3,059
+47
| +2% | +$4.68K | 0.01% | 771 |
|
|
2024
Q3 | $298K | Buy |
3,012
+70
| +2% | +$6.41K | 0.01% | 801 |
|
|
2024
Q2 | $253K | Sell |
2,942
-278
| -9% | -$21.9K | 0.01% | 833 |
|
|
2024
Q1 | $244K | Sell |
3,220
-418
| -11% | -$32.3K | 0.01% | 967 |
|
|
2023
Q4 | $276K | Buy |
3,638
+409
| +13% | +$28.5K | 0.01% | 828 |
|
|
2023
Q3 | $223K | Sell |
3,229
-157
| -5% | -$11.3K | 0.01% | 812 |
|
|
2023
Q2 | $283K | Buy |
3,386
+46
| +1% | +$3.74K | 0.02% | 762 |
|
|
2023
Q1 | $247K | Sell |
3,340
-225
| -6% | -$15.8K | 0.02% | 844 |
|
|
2022
Q4 | $252K | Sell |
3,565
-697
| -16% | -$46.5K | 0.02% | 755 |
|
|
2022
Q3 | $241K | Buy |
4,262
+13
| +0.3% | +$749 | 0.02% | 709 |
|
|
2022
Q2 | $231K | Sell |
4,249
-1,211
| -22% | -$73.9K | 0.01% | 815 |
|
|
2022
Q1 | $363K | Buy |
5,460
+335
| +7% | +$20.1K | 0.02% | 779 |
|
|
2021
Q4 | $319K | Buy |
5,125
+205
| +4% | +$13.7K | 0.01% | 937 |
|
|
2021
Q3 | $353K | Sell |
4,920
-512
| -9% | -$34.7K | 0.01% | 830 |
|
|
2021
Q2 | $351K | Buy |
5,432
+86
| +2% | +$5.32K | 0.01% | 928 |
|
|
2021
Q1 | $320K | Sell |
5,346
-506
| -9% | -$29K | 0.01% | 922 |
|
|
2020
Q4 | $325K | Buy |
+5,852
| New | +$302K | 0.01% | 775 |
|
|
2019
Q3 | – | Sell |
-5,424
| Closed | -$323K | – | 1308 |
|
|
2019
Q2 | $323K | Sell |
5,424
-332
| -6% | -$19K | 0.02% | 888 |
|
|
2019
Q1 | $356K | Sell |
5,756
-2,102
| -27% | -$119K | 0.02% | 820 |
|
|
2018
Q4 | $439K | Sell |
7,858
-2,639
| -25% | -$157K | 0.03% | 532 |
|
|
2018
Q3 | $645K | Sell |
10,497
-813
| -7% | -$46.7K | 0.02% | 617 |
|
|
2018
Q2 | $579K | Buy |
11,310
+1,162
| +11% | +$57.6K | 0.02% | 684 |
|
|
2018
Q1 | $460K | Buy |
10,148
+2,719
| +37% | +$123K | 0.02% | 855 |
|
|
2017
Q4 | $321K | Buy |
7,429
+1,107
| +18% | +$46.4K | 0.01% | 1095 |
|
|
2017
Q3 | $268K | Sell |
6,322
-2,921
| -32% | -$118K | 0.01% | 1160 |
|
|
2017
Q2 | $353K | Buy |
9,243
+1,329
| +17% | +$44.4K | 0.02% | 989 |
|
|
2017
Q1 | $229K | Sell |
7,914
-321
| -4% | -$8.99K | 0.01% | 1304 |
|
|
2016
Q4 | $218K | Buy |
+8,235
| New | +$199K | 0.01% | 1417 |
|
|
2014
Q1 | – | Sell |
-24,209
| Closed | -$381K | – | 1674 |
|
|
2013
Q4 | $381K | Buy |
24,209
+3,554
| +17% | +$53.9K | 0.02% | 1226 |
|
|
2013
Q3 | $251K | Buy |
+20,655
| New | +$266K | 0.01% | 1400 |
|
Other funds holding MMSI
CCA
NAMI
CAM
Profund Advisors's MMSI Position: Q2 2026 in Review
Profund Advisors opened a new position in Merit Medical Systems (MMSI) in Q2 2026: 3,150 shares worth $218K. The stake represents 0.01% of the portfolio and ranks #1027 among its holdings. This is a return to the name: Profund Advisors previously reported a position in MMSI as recently as Q4 2025.
Profund Advisors first reported a position in MMSI in Q3 2013 and has held it in 35 quarters since. The position peaked at $645K in Q3 2018. 403 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.
- Profund Advisors held 3,150 shares of Merit Medical Systems worth $218K as of Q2 2026.
- Merit Medical Systems was a new Profund Advisors position in Q2 2026.
- Merit Medical Systems made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #1027 holding.
- Profund Advisors first reported a position in Merit Medical Systems in Q3 2013 and has held it in 35 quarters since.
- Profund Advisors's Merit Medical Systems position peaked at $645K in Q3 2018.
- 403 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.
Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.